You are here

Ocular Scanning Instrumentation Diagnosis of Induced Trauma from Thermobaric Weapon Detonation

Award Information
Agency: Department of Defense
Branch: Army
Contract: W911NF-04-C-0033
Agency Tracking Number: 03SB2-0104
Amount: $96,973.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: SB032-032
Solicitation Number: 2003.2
Timeline
Solicitation Year: 2003
Award Year: 2004
Award Start Date (Proposal Award Date): 2004-03-01
Award End Date (Contract End Date): 2004-08-31
Small Business Information
511 Burrough St.
Morgantown, WV 26505
United States
DUNS: 093794597
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Lance Molnar
 Dir. Life Sciences Resear
 (304) 598-1101
 lmolnar@mdbiotechinc.com
Business Contact
 Christopher Kolanko
Title: President, Chief Scientif
Phone: (304) 598-1101
Email: chriskolanko@mdbiotechinc.com
Research Institution
N/A
Abstract

US military warfighters are in critical need of technologies/equipment which provide expedient, reliable and non-invasive diagnostic capabilities to aid in the evaluation and treatment of battlefield trauma. By providing quick and accurate diagnosis of the type and extent of trauma, such equipment would allow warfighters to more rapidly assess and implement the most effective course of action. Of particular concern are soldiers exposed to thermobaric blasts or other factors that may cause internal trauma within the theater of operation. Early diagnosis of internal trauma induced by a primary blast wave via a field-deployable, rapid, and non-invasive technique will provide an invaluable tool in the subsequent success of treating such conditions. The current Phase I proposal seeks to establish and validate the feasibility of using ocular biomarkers for the diagnosis/detection of specific, unapparent internal traumas resulting from overpressure exposure. Eventually, algorithms which quantitatively evaluate the determined biomarkers may be incorporated into our Ocular Scanning Instrumentation (OSI) technology. The OSI technology has thus far been developed around the capability of diagnosing exposure to chemical and biological threat agents. The resulting system will serve as an early-diagnostic system for theater of operation casualty assessment based upon generalized information obtained from ocular biomarkers.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government